Su Zhu - United Laboratories Vice President Executive Director
| ULIHFDelisted Stock | USD 1.09 0.00 0.00% |
President
Ms. Zhu Su Yan is the Vice President, Executive Director of The United Laboratories International Holdings Limited. Ms. Zhu graduated from the Medical School of Southeast University in the PRC, with a bachelor of medicine and surgery degree in 1988. She was granted a degree of Executive MBA from Business School of Nanjing University in 2005. Ms. Zhu worked in Nanjing Gulou Hospital as a neurosurgeon from 1988 to 1993, and joined Pfizer in 1994. She joined the Group in early 1995 and has served as regional manager of Jiangsu Province, manager and vice president of national hospital development department and the deputy general manager of the PRC sales team etc. Ms. Zhu has extensive experience in the sales and marketing of pharmaceutical products in the PRC and is principally responsible for the sales and marketing of the Groups products in the PRC. since 2010.
| Age | 58 |
| Tenure | 14 years |
| Phone | 852 2687 1033 |
| Web | https://www.tul.com.cn |
United Laboratories Management Efficiency
The company has return on total asset (ROA) of 0.0539 % which means that it generated a profit of $0.0539 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1056 %, meaning that it generated $0.1056 on every $100 dollars invested by stockholders. United Laboratories' management efficiency ratios could be used to measure how well United Laboratories manages its routine affairs as well as how well it operates its assets and liabilities.The United Laboratories has accumulated 221.21 M in total debt with debt to equity ratio (D/E) of 0.22, which may suggest the company is not taking enough advantage from borrowing. The United Laboratories has a current ratio of 1.57, which is within standard range for the sector. Debt can assist United Laboratories until it has trouble settling it off, either with new capital or with free cash flow. So, United Laboratories' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like The United Laboratories sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for United to invest in growth at high rates of return. When we think about United Laboratories' use of debt, we should always consider it together with cash and equity.
Similar Executives
| Found 11 records | PRESIDENT Age | ||
| Thomas Bruington | Sandstorm Gold Ltd | N/A | |
| Adam Spencer | Sandstorm Gold Ltd | N/A | |
| Richard Kinzley | Black Hills | 58 | |
| Keith Laskowski | Sandstorm Gold Ltd | N/A | |
| Brian Iverson | Black Hills | 61 | |
| Erik Keller | Black Hills | 60 | |
| George Darling | Sandstorm Gold Ltd | N/A | |
| David Awram | Sandstorm Gold Ltd | 47 | |
| Kimberly Nooney | Black Hills | 52 | |
| Jennifer Landis | Black Hills | 49 | |
| Scott Buchholz | Black Hills | 58 | |
Management Performance
| Return On Equity | 0.11 | |||
| Return On Asset | 0.0539 |
The United Laboratories Leadership Team
Elected by the shareholders, the United Laboratories' board of directors comprises two types of representatives: United Laboratories inside directors who are chosen from within the company, and outside directors, selected externally and held independent of United. The board's role is to monitor United Laboratories' management team and ensure that shareholders' interests are well served. United Laboratories' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, United Laboratories' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Karen Yang, Ma Relations | ||
| Hoi Tsoi, Executive Chairman of the Board | ||
| Xian Zou, Vice President Executive Director | ||
| Siu Choy, Executive Director | ||
| FCPA CPA, CFO Chairman | ||
| Su Zhu, Vice President Executive Director | ||
| Shou Wu, Head - Production Plant, Zhongshan | ||
| Yu Fang, Vice President Executive Director |
United Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is United Laboratories a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.11 | |||
| Return On Asset | 0.0539 | |||
| Profit Margin | 0.1 % | |||
| Operating Margin | 0.14 % | |||
| Current Valuation | 850.36 M | |||
| Shares Outstanding | 1.82 B | |||
| Shares Owned By Insiders | 50.35 % | |||
| Shares Owned By Institutions | 8.56 % | |||
| Price To Earning | 8.47 X | |||
| Price To Book | 0.67 X |
Currently Active Assets on Macroaxis
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Consideration for investing in United Pink Sheet
If you are still planning to invest in The United Laboratories check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the United Laboratories' history and understand the potential risks before investing.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |